DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by downregulating the EGFR/AKT pathway in esophageal squamous cell carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by downregulating the EGFR/AKT pathway in esophageal squamous cell carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 138, Issue 12, Pages 2940-2951
Publisher
Wiley
Online
2016-02-09
DOI
10.1002/ijc.30034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studies
- (2015) W H Shuen et al. CANCER GENE THERAPY
- A Versatile Orthotopic Nude Mouse Model for Study of Esophageal Squamous Cell Carcinoma
- (2015) Joseph Chok Yan Ip et al. Biomed Research International
- NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells
- (2015) Rebecca Kan et al. PLoS One
- Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway
- (2015) Bin Li et al. Oncotarget
- The Synergistic Effects of Alcohol and Tobacco Consumption on the Risk of Esophageal Squamous Cell Carcinoma: A Meta-Analysis
- (2014) Anoop Prabhu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Role of the mitochondrial pathway in serum deprivation-induced apoptosis of rat endplate cells
- (2014) Defang Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HATL5: A Cell Surface Serine Protease Differentially Expressed in Epithelial Cancers
- (2014) Gregory S. Miller et al. PLoS One
- KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review
- (2012) Hironobu Shigaki et al. ANNALS OF SURGICAL ONCOLOGY
- Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells
- (2012) Julie Girouard et al. GYNECOLOGIC ONCOLOGY
- Global Gene Expression Profiling and Validation in Esophageal Squamous Cell Carcinoma and Its Association with Clinical Phenotypes
- (2011) H. Su et al. CLINICAL CANCER RESEARCH
- Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis
- (2011) Edith Yuk Ting Tse et al. JOURNAL OF PATHOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Interferon-α/β and Anti-Fibroblast Growth Factor Receptor 1 Monoclonal Antibody Suppress Hepatic Cancer Cells In Vitro and In Vivo
- (2011) Shigeru Sasaki et al. PLoS One
- Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers
- (2010) Manoj K. Kashyap et al. CANCER BIOLOGY & THERAPY
- The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome
- (2010) Stephen Ho Kin Chan et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of some human genes oppositely regulated during esophageal squamous cell carcinoma formation and human embryonic esophagus development
- (2009) M. V. Zinovyeva et al. DISEASES OF THE ESOPHAGUS
- Monochromosome Transfer and Microarray Analysis Identify a Critical Tumor-Suppressive Region Mapping to Chromosome 13q14 and THSD1 in Esophageal Carcinoma
- (2008) J. M.Y. Ko et al. MOLECULAR CANCER RESEARCH
- The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase–Prostasin serine protease cascade in cultured epithelial cells
- (2007) Mengqian Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Type II transmembrane serine proteases in development and disease
- (2007) R SZABO et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More